ISL2 is a Putative Tumor Suppressor Whose Epigenetic Silencing Reprograms the Metabolism of Pancreatic Cancer.
Harun Ozturk,Harun Cingoz,Turan Tufan,Jiekun Yang,Sara J. Adair,Krishna Seshu Tummala,Cem Kuscu,Meric Kinali,Gamze Comertpay,Sarbajeet Nagdas,Bernadette J. Goudreau,Husnu Umit Luleyap, Yagmur Bingul,Timothy B. Ware, Wiliam L. Hwang,Ku-lung Hsu,David F. Kashatus,David T. Ting,Navdeep S. Chandel,Nabeel Bardeesy,Todd W. Bauer,Mazhar Adli Developmental cell(2022)
关键词
ISL2,CRISPR,pancreatic cancer,tumor suppressor
AI 理解论文
溯源树
样例